Skip to main content
SpringerLink
Log in

Prognosis After Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma Originating from Non-cirrhotic Liver

  • Hepatobiliary Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Long-term prognosis after resection of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) originating from non-cirrhotic liver is not fully clarified.

Methods

A total of 183 patients who underwent curative hepatectomy for HCC without cirrhosis were classified into two groups: HBV infection group (n = 124) and non-HBV infection group (n = 59). Long-term postoperative outcomes were compared between the two groups.

Results

The 5-year postoperative overall survival (OS) and disease-free survival (DFS) were 42.6 and 39.0 %, respectively, in the HBV infection group versus 52.3 and 46.5 % in the non-HBV infection group (both p > 0.05). When patients were subdivided according to TNM stages, OS in stages II or III HCC patients was similar between the two groups. In contrast, OS and DFS were significantly worse in stage I patients with HBV infection than those in stage I patients without HBV infection (p = 0.041 and 0.038, respectively). Preoperative serum HBV DNA >4 log10 copies/mL and vascular invasion were independent factors associated with poor prognosis (p = 0.034 and 0.017, respectively) for patients with HBV infection.

Conclusions

After hepatic resection for HCC in non-cirrhotic liver, patients with HBV infection with early-stage tumors had worse prognosis than patients without HBV infection, possibly due to the carcinogenetic potential of viral hepatitis in the remnant liver. Antiviral therapy should be considered after hepatectomy in patients with high HBV DNA levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  2. Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist. 2010;15(Suppl 4):14–22.

    Article  PubMed  Google Scholar 

  3. Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis. 2010;42:341–7.

    Article  PubMed  Google Scholar 

  4. Zhou Y, Sui C, Li B, Yin Z, Tan Y, Yang J, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol. 2010;8:55–64.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–7.

    Article  PubMed  Google Scholar 

  6. Sasaki Y, Imaoka S, Masutani S, Ohashi I, Ishikawa O, Koyama H, et al. Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery. 1992;112:515–21.

    CAS  PubMed  Google Scholar 

  7. Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg. 1995;19:35–41.

    Article  CAS  PubMed  Google Scholar 

  8. Poon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol. 2000;18:1094–101.

    CAS  PubMed  Google Scholar 

  9. Shimada M, Rikimaru T, Sugimachi K, Hamatsu T, Yamashita Y, Aishima S, et al. The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver. J Am Coll Surg. 2000;191:531–7.

    Article  CAS  PubMed  Google Scholar 

  10. Nagasue N, Ono T, Yamanoi A, Kohno H, El-Assal ON, Taniura H, et al. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg. 2001;88:515–22.

    Article  CAS  PubMed  Google Scholar 

  11. Chen MF, Tsai HP, Jeng LB, Lee WC, Yeh CN, Yu MC, et al. Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg. 2003;27:443–7.

    Article  PubMed  Google Scholar 

  12. Grazi GL, Cescon M, Ravaioli M, Ercolani G, Gardini A, Del Gaudio M, et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther. 2003;17(Suppl 2):119–29.

    Article  PubMed  Google Scholar 

  13. Chang CH, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg. 2004;139:320–5.

    Article  PubMed  Google Scholar 

  14. Dupont-Bierre E, Compagnon P, Raoul JL, Fayet G, de Lajarte-Thirouard AS, Boudjema K. Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. J Am Coll Surg. 2005;201:663–70.

    Article  PubMed  Google Scholar 

  15. Laurent C, Blanc JF, Nobili S, Sa Cunha A, le Bail B, Bioulac-Sage P, et al. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg. 2005;201:656-62.

    Google Scholar 

  16. Bège T, Le Treut YP, Hardwigsen J, Ananian P, Richa H, Campan P, et al. Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver: a 116-case European series. J Gastrointest Surg. 2007;11:619–25.

    Article  PubMed  Google Scholar 

  17. Lang H, Sotiropoulos GC, Brokalaki EI, Schmitz KJ, Bertona C, Meyer G, et al. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg. 2007;205:27–36.

    Article  PubMed  Google Scholar 

  18. Taura K, Ikai I, Hatano E, Yasuchika K, Nakajima A, Tada M, et al. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery. 2007;142:685–94.

    Article  PubMed  Google Scholar 

  19. Xu L, Huang L, Li BK, Zhang YQ, Li JQ, Yuan YF. Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver. Dig Surg. 2008;25:376–82.

    Article  PubMed  Google Scholar 

  20. Ardiles V, Sánchez Clariá R, Mazza OM, Ciardullo MA, Pekolj J, De Santibañes E. Prognostic factors after resection of hepatocellular carcinoma in the non-cirrhotic liver: presentation of 51 cases. Cir Esp. 2010;87:148–54 (in Spanish).

    Article  PubMed  Google Scholar 

  21. Smoot RL, Nagorney DM, Chandan VS, Que FG, Schleck CD, Harmsen WS, et al. Resection of hepatocellular carcinoma in patients without cirrhosis. Br J Surg. 2011;98:697–703.

    Article  CAS  PubMed  Google Scholar 

  22. Shrager B, Jibara G, Schwartz M, Roayaie S. Resection of hepatocellular carcinoma without cirrhosis. Ann Surg. 2012;255:1135–43.

    Article  PubMed  Google Scholar 

  23. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13:371–4.

    Article  Google Scholar 

  24. Lu W, Dong J, Huang Z, Guo D, Liu Y, Shi S. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI. J Gastroenterol Hepatol. 2008;23:1874–8.

    Article  PubMed  Google Scholar 

  25. Zhou YM, Sui CJ, Li B, Xu F, Kan T, Yang JM. Results of en bloc resection for hepatocellular carcinoma extending to adjacent organs. Can J Surg. 2012;55:222–6.

    PubMed Central  PubMed  Google Scholar 

  26. Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene. 2010;29:2309–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Schlüter V, Meyer M, Hofschneider PH, Koshy R, Caselmann WH. Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene. 1994;9:3335–44.

    PubMed  Google Scholar 

  28. De Maria N, Manno M, Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol. 2002;193:59–63.

    Article  PubMed  Google Scholar 

  29. Chiu CM, Yeh SH, Chen PJ, Kuo TJ, Chang CJ, Chen PJ, et al. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci USA. 2007;104:2571–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Yang WJ, Chang CJ, Yeh SH, Lin WH, Wang SH, Tsai TF, et al. Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways. Hepatology. 2009;49:1515–24.

    Article  CAS  PubMed  Google Scholar 

  31. Turati F, Edefonti V, Talamini R, Ferraroni M, Malvezzi M, Bravi F, et al. Family history of liver cancer and hepatocellular carcinoma. Hepatology. 2012;55:1416–25.

    Article  PubMed  Google Scholar 

  32. Truant S, Boleslawski E, Duhamel A, Bouras AF, Louvet A, Febvay C, et al. Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection. Eur J Surg Oncol. 2012;38:1189–96.

    Article  CAS  PubMed  Google Scholar 

  33. Witjes CD, Polak WG, Verhoef C, Eskens FA, Dwarkasing RS, Verheij J, et al. Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers. Dig Surg. 2012;29:522–8.

    Article  CAS  PubMed  Google Scholar 

  34. Young AL, Adair R, Prasad KR, Toogood GJ, Lodge JP. Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. J Am Coll Surg. 2012;214:174–83.

    Article  PubMed  Google Scholar 

  35. Faber W, Sharafi S, Stockmann M, Denecke T, Sinn B, Puhl G, et al. Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver. Surgery. 2013;153:510–7.

    Article  PubMed  Google Scholar 

  36. Thelen A, Benckert C, Tautenhahn HM, Hau HM, Bartels M, Linnemann J, et al. Liver resection for hepatocellular carcinoma in patients without cirrhosis. Br J Surg. 2013;100:130–7.

    Article  CAS  PubMed  Google Scholar 

  37. Yang T, Lu JH, Zhai J, Lin C, Yang GS, Zhao RH, et al. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study. Eur J Surg Oncol. 2012;38:683–91.

    Article  CAS  PubMed  Google Scholar 

  38. Wu CY, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, et al. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA. 2012;308:1906–14.

    Article  CAS  PubMed  Google Scholar 

  39. Urata Y, Kubo S, Takemura S, Uenishi T, Kodai S, Shinkawa H, et al. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2012;19:685–96.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Yan-Ming Zhou, Xiao-Feng Zhang, Bin Li, Cheng-Jun Sui, and Jia-Mei Yang declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Oncologic Center of Xiamen, Department of Hepatobiliary and Pancreatovascular Surgery, First Affiliated Hospital of Xiamen University, Xiamen, China

    Yan-Ming Zhou MD & Bin Li MS

  2. Department of Special Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

    Yan-Ming Zhou MD, Xiao-Feng Zhang MD, Cheng-Jun Sui MD & Jia-Mei Yang MS

Authors
  1. Yan-Ming Zhou MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao-Feng Zhang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bin Li MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cheng-Jun Sui MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jia-Mei Yang MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jia-Mei Yang MS.

Additional information

Yan-Ming Zhou and Xiao-Feng Zhang contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhou, YM., Zhang, XF., Li, B. et al. Prognosis After Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma Originating from Non-cirrhotic Liver. Ann Surg Oncol 21, 2406–2412 (2014). https://doi.org/10.1245/s10434-014-3505-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-014-3505-0

Keywords

Search

Navigation